Blom AM - Search Results

1

High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker.

Papadakos KS, Darlix A, Jacot W, Blom AM. Papadakos KS, et al. Among authors: blom am. Front Oncol. 2019 Oct 30;9:1141. doi: 10.3389/fonc.2019.01141. eCollection 2019. Front Oncol. 2019. PMID: 31737569 Free PMC article.

2

Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.

Englund E, Bartoschek M, Reitsma B, Jacobsson L, Escudero-Esparza A, Orimo A, Leandersson K, Hagerling C, Aspberg A, Storm P, Okroj M, Mulder H, Jirström K, Pietras K, Blom AM. Englund E, et al. Among authors: blom am. Oncogene. 2016 Oct 27;35(43):5585-5596. doi: 10.1038/onc.2016.98. Epub 2016 Apr 11. Oncogene. 2016. PMID: 27065333

3

Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis.

Englund E, Canesin G, Papadakos KS, Vishnu N, Persson E, Reitsma B, Anand A, Jacobsson L, Helczynski L, Mulder H, Bjartell A, Blom AM. Englund E, et al. Among authors: blom am. Oncotarget. 2017 Sep 21;8(58):98298-98311. doi: 10.18632/oncotarget.21176. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228690 Free PMC article.

4

Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling.

Papadakos KS, Bartoschek M, Rodriguez C, Gialeli C, Jin SB, Lendahl U, Pietras K, Blom AM. Papadakos KS, et al. Among authors: blom am. Matrix Biol. 2019 Aug;81:107-121. doi: 10.1016/j.matbio.2018.11.007. Epub 2018 Nov 28. Matrix Biol. 2019. PMID: 30502484

5

Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.

Gialeli C, Tuysuz EC, Staaf J, Guleed S, Paciorek V, Mörgelin M, Papadakos KS, Blom AM. Gialeli C, et al. Among authors: blom am. J Exp Clin Cancer Res. 2021 Aug 17;40(1):258. doi: 10.1186/s13046-021-02042-1. J Exp Clin Cancer Res. 2021. PMID: 34404439 Free PMC article.

6

High Levels of Expression of Cartilage Oligomeric Matrix Protein in Lymph Node Metastases in Breast Cancer Are Associated with Reduced Survival.

Papadakos KS, Hagerling C, Rydén L, Larsson AM, Blom AM. Papadakos KS, et al. Among authors: blom am. Cancers (Basel). 2021 Nov 23;13(23):5876. doi: 10.3390/cancers13235876. Cancers (Basel). 2021. PMID: 34884987 Free PMC article.

7

Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion.

Papadakos KS, Lundgren S, Gialeli C, Micke P, Mezheyeuski A, Elebro J, Jirström K, Blom AM. Papadakos KS, et al. Among authors: blom am. Oncoimmunology. 2022 Aug 18;11(1):2111906. doi: 10.1080/2162402X.2022.2111906. eCollection 2022. Oncoimmunology. 2022. PMID: 35990519 Free PMC article.

8

Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.

Papadakos KS, Ekström A, Slipek P, Skourti E, Reid S, Pietras K, Blom AM. Papadakos KS, et al. Among authors: blom am. J Exp Clin Cancer Res. 2022 Dec 29;41(1):363. doi: 10.1186/s13046-022-02565-1. J Exp Clin Cancer Res. 2022. PMID: 36578014 Free PMC article.

9

Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression.

Blom AM, Gialeli C, Hagerling C, Berntsson J, Jirström K, Papadakos KS. Blom AM, et al. Front Immunol. 2023 May 3;14:1167659. doi: 10.3389/fimmu.2023.1167659. eCollection 2023. Front Immunol. 2023. PMID: 37207219 Free PMC article.

10

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.

Gialeli C, Tuysuz EC, Staaf J, Guleed S, Paciorek V, Mörgelin M, Papadakos KS, Blom AM. Gialeli C, et al. Among authors: blom am. J Exp Clin Cancer Res. 2023 May 30;42(1):135. doi: 10.1186/s13046-023-02703-3. J Exp Clin Cancer Res. 2023. PMID: 37248519 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters